These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
723 related articles for article (PubMed ID: 34297484)
21. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
22. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma. Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453 [TBL] [Abstract][Full Text] [Related]
23. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
24. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma. Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ Gene; 2020 Mar; 730():144316. PubMed ID: 31884109 [TBL] [Abstract][Full Text] [Related]
26. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Aizemaiti R; Wu Z; Tang J; Yan H; Lv X Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814 [TBL] [Abstract][Full Text] [Related]
27. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
28. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2. Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387 [TBL] [Abstract][Full Text] [Related]
29. The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway. Luan T; Zhang TY; Lv ZH; Guan BX; Xu JY; Li J; Li MX; Hu SL FEBS Open Bio; 2021 May; 11(5):1504-1515. PubMed ID: 33683834 [TBL] [Abstract][Full Text] [Related]
30. A Novel Role of Arrhythmia-Related Gene Chang KT; Wu HJ; Liu CW; Li CY; Lin HY Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216393 [TBL] [Abstract][Full Text] [Related]
31. FANCA promotes lung adenocarcinoma progression and is a potential target for epitope vaccine immunotherapy. Kang Y; Zhong R; Gan Y; You J; Chen J; Chen F; Chen L J Transl Med; 2024 Oct; 22(1):911. PubMed ID: 39375712 [TBL] [Abstract][Full Text] [Related]
32. Major Facilitator Superfamily Domain Containing 12 Is Overexpressed in Lung Cancer and Exhibits an Oncogenic Role in Lung Adenocarcinoma Cells. Zhao W; Hu X; Chen Z; Li X DNA Cell Biol; 2024 Jul; 43(7):331-340. PubMed ID: 38687351 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD. Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996 [TBL] [Abstract][Full Text] [Related]
34. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression. He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325 [TBL] [Abstract][Full Text] [Related]
35. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma. Wei S; Xing J; Lu K; Wang K; Yu W Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value and molecular mechanisms of OAS1 in lung adenocarcinoma. Wang L; Gao L; Ding F; Gao K; Liu Q; Yin X BMC Pulm Med; 2024 Sep; 24(1):473. PubMed ID: 39334033 [TBL] [Abstract][Full Text] [Related]
37. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. Zhao W; Xie Y Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400 [TBL] [Abstract][Full Text] [Related]
38. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642 [TBL] [Abstract][Full Text] [Related]
39. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
40. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma. Hu Y; Liu Y; Ma C; Ai K Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]